Does hydroxychloroquine reduce mortality for COVID-19?

Gallus, Silvano; Clavenna, Antonio; Lugo, Alessandra

Gallus, Silvano; Clavenna, Antonio; Lugo, Alessandra.

Gallus S; Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. Electronic address: silvano.gallus@marionegri.it.
Clavenna A; Department of Public Health, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Lugo A; Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Eur J Intern Med ; 82: 21-22, 2020 12.

Article in English | MEDLINE | ID: covidwho-1059068

Subject(s)

COVID-19; Hydroxychloroquine; Azithromycin; Humans; Hydroxychloroquine/therapeutic use; Italy; SARS-CoV-2

Keywords

Azithromycin; COVID-19; Hydroxychloroquine; Mortality

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Hydroxychloroquine Limits: Humans Country/Region as subject: Europa Language: English Journal: Eur J Intern Med Journal subject: Internal Medicine Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google